These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 31237223)

  • 1. Association Between Fat-soluble Vitamins and Lipid Profile in the Overweight Population.
    Piran S; Sarmasti S; Shabani M; Kakavandi N; Hosseni B; Khosravi M; Resaee S; Soltanmohammadi E; Naseri F; Mohammadi A; Najafi M
    Recent Pat Food Nutr Agric; 2020; 11(1):56-62. PubMed ID: 31237223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of plasma small dense LDL cholesterol with PCSK9 levels in patients with angiographically proven coronary artery disease.
    Zhang Y; Xu RX; Li S; Zhu CG; Guo YL; Sun J; Li JJ
    Nutr Metab Cardiovasc Dis; 2015 Apr; 25(4):426-33. PubMed ID: 25770756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel circulating lipid measurements for current dyslipidemias in non-treated patients undergoing coronary angiography: PCSK9, apoC3 and sdLDL-C.
    Li S; Zhao X; Zhang Y; Zhu CG; Guo YL; Wu NQ; Xu RX; Qing P; Gao Y; Sun J; Liu G; Dong Q; Li JJ
    Oncotarget; 2017 Feb; 8(7):12333-12341. PubMed ID: 27713142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dietary high oleic canola oil supplemented with docosahexaenoic acid attenuates plasma proprotein convertase subtilisin kexin type 9 (PCSK9) levels in participants with cardiovascular disease risk: A randomized control trial.
    Pu S; Rodríguez-Pérez C; Ramprasath VR; Segura-Carretero A; Jones PJ
    Vascul Pharmacol; 2016 Dec; 87():60-65. PubMed ID: 27374222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating PCSK9 levels are positively correlated with NMR-assessed atherogenic dyslipidaemia in patients with high cardiovascular risk.
    Guardiola M; Plana N; Ibarretxe D; Cabré A; González M; Ribalta J; Masana L
    Clin Sci (Lond); 2015 Jun; 128(12):877-82. PubMed ID: 25649668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ABO blood group in relation to plasma lipids and proprotein convertase subtilisin/kexin type 9.
    Li S; Xu RX; Guo YL; Zhang Y; Zhu CG; Sun J; Li JJ
    Nutr Metab Cardiovasc Dis; 2015 Apr; 25(4):411-7. PubMed ID: 25466598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating PCSK9 affects serum LDL and cholesterol levels more than SREBP-2 expression.
    Mohammadi A; Shabani M; Naseri F; Hosseni B; Soltanmohammadi E; Piran S; Najafi M
    Adv Clin Exp Med; 2017 Jul; 26(4):655-659. PubMed ID: 28691419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between proprotein convertase subtilisin/kexin 9 (PCSK9) and lipoprotein subclasses in children with type 1 diabetes mellitus: Effects of glycemic control.
    Bojanin D; Vekic J; Milenkovic T; Vukovic R; Zeljkovic A; Stefanovic A; Janac J; Ivanisevic J; Mitrovic K; Miljkovic M; Spasojevic-Kalimanovska V
    Atherosclerosis; 2019 Jan; 280():14-20. PubMed ID: 30453116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of plasma apolipoprotein M with proprotein convertase subtilisin-kexin type 9 levels in non-diabetic subjects.
    Kappelle PJ; Lambert G; Dahlbäck B; Nielsen LB; Dullaart RP
    Atherosclerosis; 2011 Feb; 214(2):492-4. PubMed ID: 21122852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum proprotein convertase subtilisin kexin type 9 is correlated directly with serum LDL cholesterol.
    Alborn WE; Cao G; Careskey HE; Qian YW; Subramaniam DR; Davies J; Conner EM; Konrad RJ
    Clin Chem; 2007 Oct; 53(10):1814-9. PubMed ID: 17702855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationships between anthropometric measurements, serum vitamin A and E concentrations and lipid profiles in overweight and obese subjects.
    Viroonudomphol D; Pongpaew P; Tungtrongchitr R; Changbumrung S; Tungtrongchitr A; Phonrat B; Vudhivai N; Schelp FP
    Asia Pac J Clin Nutr; 2003; 12(1):73-9. PubMed ID: 12737014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proprotein Convertase Subtilisin Kexin 9 (PCSK9) and nonHDL particles rise during normal pregnancy and differ by BMI.
    Wild RA; Weedin E; Cox K; Zhao YD; Wrenn DS; Lopez D; Wooten CJ; Melendez QM; Myers D; Hansen KR
    J Clin Lipidol; 2022; 16(4):483-490. PubMed ID: 35717446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma proprotein convertase subtilisin kexin type 9 levels are related to markers of cholesterol synthesis in familial combined hyperlipidemia.
    Brouwers MC; Konrad RJ; van Himbergen TM; Isaacs A; Otokozawa S; Troutt JS; Schaefer EJ; van Greevenbroek MM; Stalenhoef AF; de Graaf J
    Nutr Metab Cardiovasc Dis; 2013 Nov; 23(11):1115-21. PubMed ID: 23333725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum proprotein convertase subtilisin/kexin type 9 concentration is not increased by plant stanol ester consumption in normo- to moderately hypercholesterolaemic non-obese subjects. The BLOOD FLOW intervention study.
    Simonen P; Stenman UH; Gylling H
    Clin Sci (Lond); 2015 Sep; 129(5):439-46. PubMed ID: 25857271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamins, lipids and lipoproteins in a healthy elderly population.
    Hooper PL; Hooper EM; Hunt WC; Garry PJ; Goodwin JS
    Int J Vitam Nutr Res; 1983; 53(4):412-9. PubMed ID: 6668142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV and Hepatitis C-Coinfected Patients Have Lower Low-Density Lipoprotein Cholesterol Despite Higher Proprotein Convertase Subtilisin Kexin 9 (PCSK9): An Apparent "PCSK9-Lipid Paradox".
    Kohli P; Ganz P; Ma Y; Scherzer R; Hur S; Weigel B; Grunfeld C; Deeks S; Wasserman S; Scott R; Hsue PY
    J Am Heart Assoc; 2016 Apr; 5(5):. PubMed ID: 27130349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased serum PCSK9, a potential biomarker to screen for periodontitis, and decreased total bilirubin associated with probing depth in a Japanese community survey.
    Tabeta K; Hosojima M; Nakajima M; Miyauchi S; Miyazawa H; Takahashi N; Matsuda Y; Sugita N; Komatsu Y; Sato K; Ishikawa T; Akiishi K; Yamazaki K; Kato K; Saito A; Yoshie H
    J Periodontal Res; 2018 Jun; 53(3):446-456. PubMed ID: 29516504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of subclinical hypothyroidism on serum lipid profile, PCSK9 levels and CD36 expression on monocytes.
    Fazaeli M; Khoshdel A; Shafiepour M; Rohban M
    Diabetes Metab Syndr; 2019; 13(1):312-316. PubMed ID: 30641718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The expression and clinical significance of proprotein convertase subtilisin kexin 9 in rheumatoid arthritis].
    Du Q; Yu XJ; Li HJ; Guan SQ; Zhang ZY; Mei YF
    Zhonghua Nei Ke Za Zhi; 2017 Sep; 56(9):655-659. PubMed ID: 28870033
    [No Abstract]   [Full Text] [Related]  

  • 20. Independent Link Between Levels of Proprotein Convertase Subtilisin/Kexin Type 9 and FABP4 in a General Population Without Medication.
    Furuhashi M; Omori A; Matsumoto M; Kataoka Y; Tanaka M; Moniwa N; Ohnishi H; Yoshida H; Saitoh S; Shimamoto K; Miura T
    Am J Cardiol; 2016 Jul; 118(2):198-203. PubMed ID: 27241838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.